Principles and Practice of Allergy 2026 by Andrew M. Lerner, MD

Principles and Practice of Allergy 2026

By

Description

Every allergist has stared at a test result that should have answered the question — and realized it only deepened it. A positive peanut IgE without component data is not a diagnosis; a dual-positive bee and yellow jacket venom panel without Api m 1 and Ves v 5 is not an immunotherapy prescription; an elevated tryptase without a baseline is not confirmation of anaphylaxis — and every one of these misreads changes patient outcomes. This book gives you a systematic framework for converting test results into clinical decisions across every domain of allergy and clinical immunology — not theory, but the five-step reasoning sequence that turns a panel of numbers into the right action at the right time. Inside this book: • The Test-to-Diagnosis Decoder System — a repeatable five-slot framework embedded in every chapter that takes any allergy result from raw data to clinical decision, including the interpretation trap that sends most clinicians in the wrong direction • Component-resolved diagnostics in practice — distinguish Ara h 2 true peanut allergy from Ara h 8 cross-reactive PFAS, Cor a 14 systemic hazelnut risk from Cor a 1 oral allergy, and Ves v 5 genuine yellow jacket sensitization from MUXF3 carbohydrate artifact • Biologic selection across comorbidities — identify which single agent addresses the patient with concurrent severe atopic dermatitis, eosinophilic asthma, CRSwNP, and EoE without a second prescription • Anaphylaxis management beyond epinephrine — refractory protocols, beta-blocker considerations, glucagon timing, and the biphasic observation standards that determine safe discharge • Mastocytosis and mast cell activation — baseline tryptase interpretation, HAT versus ISM distinction, and the indefinite VIT standard that elevated tryptase demands • Immunodeficiency recognition at the allergy visit — the Pneumovax response interpretation, DHR flow cytometry reading, and the five-year diagnostic delay that destroys lung architecture before CVID is ever named Written for allergy and immunology fellows, practicing allergist-immunologists, clinical immunologists, pulmonologists, dermatologists, and advanced practitioners who manage type 2 inflammatory disease and immune dysregulation at every level of complexity.

More Andrew M. Lerner, MD Books